Elite Suppressors Harbor Low Levels of Integrated HIV DNA and High Levels of 2-LTR Circular HIV DNA Compared to HIV+ Patients On and Off HAART

English version České info

Elite suppressors (ES) are a rare population of HIV-infected individuals that are capable of naturally controlling the infection without the use of highly active anti-retroviral therapy (HAART). Patients on HAART often achieve viral control to similar (undetectable) levels. Accurate and sensitive methods to measure viral burden are needed to elucidate important differences between these two patient populations in order to better understand their mechanisms of control. Viral burden quantification in ES patients has been limited to measurements of total DNA in PBMC, and estimates of Infectious Units per Million cells (IUPM). There appears to be no significant difference in the level of total HIV DNA between cells from ES patients and patients on HAART. However, recovering infectious virus from ES patient samples is much more difficult, suggesting their reservoir size should be much smaller than that in patients on HAART. Here we find that there is a significant difference in the level of integrated HIV DNA in ES patients compared to patients on HAART, providing an explanation for the previous results. When comparing the level of total to integrated HIV DNA in these samples we find ES patients have large excesses of unintegrated HIV DNA. To determine the composition of unintegrated HIV DNA in these samples, we measured circular 2-LTR HIV DNA forms and found ES patients frequently have high levels of 2-LTR circles in PBMC. We further show that these high levels of 2-LTR circles are not the result of inefficient integration in ES cells, since HIV integrates with similar efficiency in ES and normal donor cells. Our findings suggest that measuring integration provides a better surrogate of viral burden than total HIV DNA in ES patients. Moreover, they add significantly to our understanding of the mechanisms that allow viral control and reservoir maintenance in this unique patient population.

Vyšlo v časopise: Elite Suppressors Harbor Low Levels of Integrated HIV DNA and High Levels of 2-LTR Circular HIV DNA Compared to HIV+ Patients On and Off HAART. PLoS Pathog 7(2): e32767. doi:10.1371/journal.ppat.1001300
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1001300

Souhrn

Zdroje

1. BlanksonJN

SilicianoRF

2008 Elite suppression of HIV-1 replication. Immunity 29 845 847

2. LambotteO

BoufassaF

MadecY

NguyenA

GoujardC

2005 HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication. Clin Infect Dis 41 1053 1056

3. DeeksSG

WalkerBD

2007 Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity 27 406 416

4. BlanksonJN

2010 Effector mechanisms in HIV-1 infected elite controllers: highly active immune responses? Antiviral Res 85 295 302

5. MiguelesSA

ConnorsM

2010 Long-term nonprogressive disease among untreated HIV-infected individuals: clinical implications of understanding immune control of HIV. JAMA 304 194 201

6. HubertJB

BurgardM

DussaixE

TamaletC

DeveauC

2000 Natural history of serum HIV-1 RNA levels in 330 patients with a known date of infection. The SEROCO Study Group. AIDS 14 123 131

7. LefrereJJ

MariottiM

Morand-JoubertL

ThauvinM

Roudot-ThoravalF

1999 Plasma human immunodeficiency virus RNA below 40 Copies/mL is rare in untreated persons even in the first years of infection. J Infect Dis 180 526 529

8. LassenKG

LobritzMA

BaileyJR

JohnstonS

NguyenS

2009 Elite suppressor-derived HIV-1 envelope glycoproteins exhibit reduced entry efficiency and kinetics. PLoS Pathog 5 e1000377

9. LearmontJC

GeczyAF

MillsJ

AshtonLJ

Raynes-GreenowCH

1999 Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. New Engl J Med 340 1715 1722

10. BaileyJR

O'ConnellK

YangHC

HanY

XuJ

2008 Transmission of human immunodeficiency virus type 1 from a patient who developed AIDS to an elite suppressor. J Virol 82 7395 7410

11. DingesWL

RichardtJ

FriedrichD

JalbertE

LiuY

2010 Virus-specific CD8+ T-cell responses better define HIV disease progression than HLA genotype. J Virol 84 4461 4468

12. MiguelesSA

OsborneCM

RoyceC

ComptonAA

JoshiRP

2008 Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control. Immunity 29 1009 1021

13. PereyraF

AddoMM

KaufmannDE

LiuY

MiuraT

2008 Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. J Infect Dis 197 563 571

14. DinosoJB

KimSY

SilicianoRF

BlanksonJN

2008 A comparison of viral loads between HIV-1-infected elite suppressors and individuals who receive suppressive highly active antiretroviral therapy. Clin Infect Dis 47 102 104

15. BlanksonJN

BaileyJR

ThayilS

YangHC

LassenK

2007 Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressors. J Virol 81 2508 2518

16. HatanoH

DelwartEL

NorrisPJ

LeeTH

Dunn-WilliamsJ

2009 Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy. J Virol 83 329 335

17. JulgB

PereyraF

BuzonMJ

Piechocka-TrochaA

ClarkMJ

2010 Infrequent recovery of HIV from but robust exogenous infection of activated CD4(+) T cells in HIV elite controllers. Clin Infect Dis 51 233 238

18. RichmanDD

MargolisDM

DelaneyM

GreeneWC

HazudaD

2009 The challenge of finding a cure for HIV infection. Science 323 1304 1307

19. ChunTW

EngelD

BerreyMM

SheaT

CoreyL

1998 Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection. Proc Natl Acad Sci U S A USA 95 8869 8873

20. LiszewskiMK

YuJJ

O'DohertyU

2009 Detecting HIV-1 integration by repetitive-sampling Alu-gag PCR. Methods 47 254 260

21. YuJJ

WuTL

LiszewskiMK

DaiJ

SwiggardWJ

2008 A more precise HIV integration assay designed to detect small differences finds lower levels of integrated DNA in HAART treated patients. Virology 379 78 86

22. AgostoLM

LiszewskiMK

MexasA

GrafE

PaceM

2010 Patients on HAART often have an excess of unintegrated HIV DNA: Implications for monitoring reservoirs. Virology 409 46 53

23. RouziouxC

HubertJB

BurgardM

DeveauC

GoujardC

2005 Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+ T cell counts. J Infect Dis 192 46 55

24. BrusselA

MathezD

Broche-PierreS

LancarR

CalvezT

2003 Longitudinal monitoring of 2-long terminal repeat circles in peripheral blood mononuclear cells from patients with chronic HIV-1 infection. AIDS 17 645 652

25. MorleseJ

TeoIA

ChoiJW

GazzardB

ShaunakS

2003 Identification of two mutually exclusive groups after long-term monitoring of HIV DNA 2-LTR circle copy number in patients on HAART. AIDS 17 679 683

26. FischerM

TrkolaA

JoosB

HafnerR

JollerH

2003 Shifts in cell-associated HIV-1 RNA but not in episomal HIV-1 DNA correlate with new cycles of HIV-1 infection in vivo. Antivir Ther 8 97 104

27. BuzonM

MassanellaM

LibreJM

EsteveA

DahlV

2009 HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects. Nat Med 16 460 465

28. O'DohertyU

SwiggardWJ

JeyakumarD

McGainD

MalimMH

2002 A sensitive, quantitative, assay for Human Immunodeficiency Virus type 1 integration. J Virol 76: 10,942-910, 950

29. BrusselA

DelelisO

SonigoP

2005 Alu-LTR real-time nested PCR assay for quantifying integrated HIV-1 DNA. Methods Mol Biol 304 139 154

30. ButlerSL

HansenMST

BushmanFD

2001 A quantitative assay for HIV DNA integration in vivo. Nat Med 7 631 634

31. MiguelesSA

WeeksKA

NouE

BerkleyAM

RoodJE

2009 Defective HIV-Specific CD8+ T Cell Polyfunctionality, Proliferation and Cytotoxicity Are Not Restored by Antiretroviral Therapy. J Virol 83 11876 11889

32. SvarovskaiaES

BarrR

ZhangX

PaisGC

MarchandC

2004 Azido-containing diketo acid derivatives inhibit human immunodeficiency virus type 1 integrase in vivo and influence the frequency of deletions at two-long-terminal-repeat-circle junctions. J Virol 78 3210 3222

33. HazudaDJ

FelockP

WitmerM

WolfeA

StilmockK

2000 Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells. Science 287 646 650

34. EnglemanA

BushmanFD

CraigieR

1993 Identification of discrete functional domains of HIV-1 integrase and their organization within an active multimeric complex. EMBO J 12 3269 3275

35. Ansari-LariMA

DonehowerLA

GibbsRA

1995 Analysis of human immunodeficiency virus type 1 integrase mutants. Virology 211 332 335

36. CoffinJM

HughesSH

VarmusHE

1997 Retroviruses. Cold Spring Harbor, NY Cold Spring Harbor Laboratory Press 171 172

37. CaraA

GuarnacciaF

ReitzMS

GalloRC

LoriF

1995 Self-limiting, cell type-dependent replication of an integrase-defective human immunodeficiency virus type 1 in human primary macrophages but not T lymphocytes. Virology 208 242 248

38. EnglundG

TheodoreTS

FreedEO

EngelmanA

MartinMA

1995 Integration is required for productive infection of monocyte-derived macrophages by Human Immunodeficiency Virus type 1. J Virol 69 3216 3219

39. SakaiH

KawamuraM

SakuragiJ

SakuragiS

ShibataR

1993 Integration is essential for efficient gene expression of human immunodeficiency virus type 1. J Virol 67 1169 1174

40. StevensonM

HaggertyS

LamonicaCA

MeierCM

WelchSK

1990 Integration is not necessary for expression of human immunodeficiency virus type 1 protein products. J Virol 64 2421 2425

41. WiskerchenM

MeusingMA

1995 Identification and characterization of a temperature-sensitive mutant of human immunodeficiency virus type 1 by alanine scanning mutagenesis of the integrase gene. J Virol 69 597 601

42. FinziD

HermankovaM

PiersonT

CarruthLM

BuckC

1997 Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278 1295 1300

43. SilicianoJD

KajdasJ

FinziD

QuinnTC

ChadwickK

2003 Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat Med 9 727 728

44. IzopetJ

CazabatM

PasquierC

Sandres-SauneK

BonnetE

2002 Evolution of total and integrated HIV-1 DNA and change in DNA sequences in patients with sustained plasma virus suppression. Virology 302 393 404

45. KoelschKK

LiuL

HaubrichR

MayS

HavlirD

2008 Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro. J Infect Dis 197 411 419

46. IbanezA

PuigT

EliasJ

ClotetB

RuizL

1999 Quantification of integrated and total HIV-1 DNA after long-term highly active antiretroviral therapy in HIV-1-infected patients. Aids 13 1045 1049

47. ChomontN

El-FarM

AncutaP

TrautmannL

ProcopioFA

2009 HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med 15 893 900

48. O'ConnellKA

BrennanTP

BaileyJR

RaySC

SilicianoRF

2010 Control of HIV-1 in elite suppressors despite ongoing replication and evolution in plasma virus. J Virol 84 7018 7028

49. MensH

KearneyM

WiegandA

ShaoW

Schonning

2010 HIV-1 continues to replicate and evolve in patients with natural control of HIV infection. J Virol 84 12971 12981

50. SedaghatAR

RastegarDA

O'ConnellKA

DinosoJB

WilkeCO

2009 T cell dynamics and the response to HAART in a cohort of HIV-1-infected elite suppressors. Clin Infect Dis 49 1763 1766

51. de QuirosJC

ShupertWL

McNeilAC

Gea-BanaclocheJC

FlaniganM

2000 Resistance to replication of human immunodeficiency virus challenge in SCID-Hu mice engrafted with peripheral blood mononuclear cells of nonprogressors is mediated by CD8(+) T cells and associated with a proliferative response to p24 antigen. J Virol 74 2023 2028

52. RabiSA

O'ConnellKA

NikolaevaD

BaileyJR

JilekBL

2010 Unstimulated Primary CD4+ T Cells from HIV Type 1 Positive Elite Suppressors are Fully Susceptible to HIV-1 Entry and Productive Infection. J Virol 85 979 986

53. MiguelesSA

LaboricoAC

ImamichiH

ShupertWL

RoyceC

2003 The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences. J Virol 77 6889 6898

54. BettsMR

NasonMC

WestSM

De RosaSC

MiguelesSA

2006 HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107 4781 4789

55. Saez-CirionA

LacabaratzC

LambotteO

VersmisseP

UrrutiaA

2007 HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype. Proc Natl Acad Sci U S A 104 6776 6781

56. Saez-CirionA

SinetM

ShinSY

UrrutiaA

VersmisseP

2009 Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: association with Gag-specific CD8 T cell responses. J Immunol 182 7828 7837

57. HerspergerAR

PereyraF

NasonM

DemersK

ShethP

2007 Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control. PLoS Pathog 6 e1000917

58. PereyraF

PalmerS

MiuraT

BlockBL

WiegandA

2009 Persistent low-level viremia in HIV-1 elite controllers and relationship to immunologic parameters. J Infect Dis 200 984 990

59. BaileyJR

WilliamsTM

SilicianoRF

BlanksonJN

2006 Maintenance of viral suppression in HIV-1-infected HLA-B*57+ elite suppressors despite CTL escape mutations. J Exp Med 203 1357 1369

60. BaileyJR

BrennanTP

O'ConnellKA

SilicianoRF

BlanksonJN

2009 Evidence of CD8+ T-cell-mediated selective pressure on human immunodeficiency virus type 1 nef in HLA-B*57+ elite suppressors. J Virol 83 88 97

61. OwenRE

HeitmanJW

HirschkornDF

LanteriMC

BiswasHH

2010 HIV+ elite controllers have low HIV-specific T-cell activation yet maintain strong, polyfunctional T-cell responses. AIDS 24 1095 1105

62. HuntPW

BrenchleyJ

SinclairE

McCuneJM

RolandM

2008 Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis 197 126 133

63. ChaseAJ

YangHC

ZhangH

BlanksonJN

SilicianoRF

2008 Preservation of FoxP3+ regulatory T cells in the peripheral blood of human immunodeficiency virus type 1-infected elite suppressors correlates with low CD4+ T-cell activation. J Virol 82 8307 8315

64. ButlerSL

JohnsonEP

BushmanFD

2002 Human Immunodeficiency Virus cDNA Metabolism: Notable Stability of Two-Long Terminal Repeat Circles. Journal of Virology 76 3739 3747

65. AgostoLM

YuJJ

DaiJ

KaletskyR

MonieD

2007 HIV-1 integrates into resting CD4+ T cells even at low inoculums as demonstrated with an improved assay for HIV-1 integration. Virology 368 60 72